Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China

Background:Streptococcus pneumoniae infection among adults, especially in adults over 60 years old in China results in a large number of hospitalizations and a substantial financial burden. This study assessed the vaccine effectiveness (VE) of 23-valent pneumococcal polysaccharide vaccine (PPV23) ag...

Full description

Bibliographic Details
Main Authors: Xiaodong Sun, Xiang Guo, Jing Qiu, Genming Zhao, Xinxin Xu, Abram L. Wagner, Hongli Jiang, Zhuoying Huang, Jia Ren, Xiaoying Ma, Xiufang Liang, Yao Yao, Jialing Wu, Yihan Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Public Health
Subjects:
effectiveness
PPV23
pneumococcal diseases
elderly
test-negative design
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.620531/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2021.620531/full

Similar Items